Health
NCDC Issues Public Health Advisory On Human Metapneumovirus (HMPV)
There is no specific antiviral treatment or vaccine for HMPV.
The Nigeria Centre for Disease Control and Prevention (NCDC) has issued the following Public Health Advisory on Human Metapneumovirus (HMPV) Awareness, Preparedness, and Prevention.
The document released by, Dr. Jide Idris, the Director – GeneralNigeria Centre for Disease Control and Prevention, said :
” NCDC is committed to safeguarding the health of all Nigerians. In response to recent reports of increased Human Metapneumovirus (HMPV) activity in China and other affected regions, as well as growing public interest in the matter, the NCDC in collaboration with the Federal Ministry of Health and Social Welfare is closely monitoring global developments.
We aim to provide timely, accurate information and guidance to keep the Nigerian public informed and prepared. Global situation update.
It is important to note that the rumor circulating about the World Health Organization (WHO) declaring HMPV a Public Health Emergency of International Concern (PHEIC) is false and should be disregarded.
The WHO has not made such a declaration. Recent reports indicate a significant rise in Human Metapneumovirus (HMPV) cases in China, as well as increased respiratory infections linked to HMPV in countries such as the United Kingdom (UK), France, and Germany, particularly during the winter season.
The UK Health Security Agency (UKHSA) has highlighted a notable rise in hospital admissions due to HMPV-related complications, especially among children under five and older adults in care homes.
This trend emphasizes the need for heightened preparedness and vigilance.
Current Situation in Nigeria
Nigeria operates a National Influenza Sentinel Surveillance (NISS) system, comprising sentinel sites distributed across the six geopolitical zones of the country.
These sites, which include tertiary and secondary health facilities, monitor Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI).
As of January 6, 2025, data from this surveillance system does not indicate any unusual increase in respiratory infections, including those caused by Human Metapneumovirus (HMPV).
However, given the global trends in HMPV cases, the Nigeria Centre for Disease Control and Prevention (NCDC) is proactively implementing measures to strengthen the country’s preparedness and response capacity.
NCDC Preparedness Measures
The NCDC is closely monitoring the situation and has implemented the following actions to ensure public health safety:
1. Dynamic Risk Assessment
On January 6, 2025, the Nigeria Centre for Disease Control and Prevention (NCDC), in collaboration with the Federal Ministry of Health and partners such as the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (USCDC), and the UK Health Security Agency (UKHSA), conducted a dynamic risk assessment for Human Metapneumovirus (HMPV).
The assessment classified the risk of HMPV for Nigeria as moderate.
This evaluation will inform and guide preparedness efforts, decision-making, and response strategies to mitigate potential impacts.
2. Public Health Advisory:
Issued this advisory to provide Nigerians with up-to-date information on preparedness actions and preventive measures.
3. Point of Entry (POE):
The Nigeria Centre for Disease Control and Prevention (NCDC), in collaboration with Port Health Authorities, is taking proactive steps to ensure robust preparedness at all international points of entry (PoEs) in response to the dynamic risk assessment for Human Metapneumovirus (HMPV).
These measures are designed to mitigate the potential risk of HMPV transmission through international travel. Key actions include
▪︎ Conducting a comprehensive situation analysis at all international PoEs to assess current readiness levels.
▪︎ An Entry Implementation Protocol on HMPV, approved by the Honourable Minister of Health and Social Welfare, is being developed and will be distributed to all points of entry to guide response activities.
▪︎ In addition, quarantine facilities are being identified and prepared to manage any suspected or confirmed cases if required.
▪︎ Infection Prevention and Control (IPC) materials are being deployed to PoEs to ensure adherence to hygiene and safety protocols.
▪︎ Information, Education, and Communication (IEC) materials are being developed and distributed to raise awareness and provide clear guidelines for frontline staff and travelers at PoEs.
4. Enhanced Surveillance and Laboratory Diagnosis:
The National Influenza Sentinel Surveillance (NISS) sites across the six geopolitical zones monitor Influenza-like Illness (ILI) and Severe Acute Respiratory Infections (SARI).
This platform, which is already testing for COVID-19, will now also start testing for HMPV. Provisions will be made to increase the number of tests conducted.
Additionally, laboratories in states with international airports will be supported to enable them to test for HMPV.
5. Infection Prevention and Control (IPC):
Advisories have been issued to hospitals nationwide on enhanced IPC practices, including proper hand hygiene, environmental cleaning, respiratory hygiene, and cough etiquette.
All health facilities are required to identify an appropriate isolation room where cases can be quickly isolated while receiving care.
6. Case Management Preparedness:
Collaborating with state governments and healthcare facilities to provide training for healthcare workers to ensure adequate case management teams are in place and ready to respond if needed.
This will ensure that healthcare workers are able to provide appropriate care and maintain a high index of suspicion. Supportive care and an emphasis on a high index of suspicion are crucial.
We are requesting state governments to activate their treatment centers or isolation centers to ensure they are prepared to manage cases appropriately.
7. Stockpiling of Medical Countermeasures:
Relevant materials such as PPEs (face masks, hand gloves, hand hygiene supplies, and other essential IPC items) have been stockpiled for rapid deployment if required.
Additionally, laboratory consumables, reagents, and other necessary supplies have also been stockpiled to ensure readiness.
Risk Communication and Community Engagement:Engaging with the public through clear and accurate messages to address concerns, dispel misinformation, and encourage appropriate health-seeking behaviors.
We work in close collaboration with state risk communication and community engagement pillars, health educators, and other trusted voices, such as the media.
These efforts reflect NCDC’s commitment to proactive coordination and response at all levels of public health.
Public Advisory What is HMPV?
Human Metapneumovirus (HMPV) is a respiratory virus that can cause illnesses ranging from mild cold-like symptoms to severe respiratory infections, particularly in:
• Young children •
Older adults
• Individuals with weakened immune systems
There is no specific antiviral treatment or vaccine for HMPV.
Supportive care, such as rest, hydration, and fever management, remains the primary approach to recovery.
Symptoms
• Cough
• Fever
• Nasal congestion
• Shortness of breath
• Wheezing
• Bronchitis or pneumonia (in vulnerable populations such as very young children, older people, patients with low immunity such and those on cancer treatment, uncontrolled diabetes etc).
The incubation period is 3-5 days after exposure, and infections typically resolve within 2-5 days with supportive care.
We urge the public to adhere to the preventive measures outlined above and to seek medical attention if experiencing symptoms consistent with HMPV infection.
However, high-risk populations may experience complications.
Transmission HMPV spreads through:
• Respiratory droplets from coughing and sneezing
• Close personal contact (e.g., touching or shaking hands)
• Touching contaminated surfaces and then touching the face.
Overcrowding and poor ventilation can lead to increased transmission, e.g., in congregate settings such as correctional centers and poorly managed IDPs.
Preventive Measures
To reduce the risk of HMPV infection, the public is advised to follow these preventive steps:
For the General Public:
• Hand Hygiene: Wash hands frequently with soap and water for at least 20 seconds.
• Respiratory Etiquette: Cover your mouth and nose with a tissue or elbow when coughing or sneezing. Cover your mouth an nose with face mask if you are experiencing flu like symptoms.
• Avoid Close Contact: Maintain distance from individuals showing symptoms of respiratory illness.
• Avoid overcrowded places.
• Disinfect Surfaces: Regularly clean and disinfect frequently touched objects and surfaces.
• Self-Isolation: Stay home if experiencing symptoms to prevent spreading the virus. As is correct parctice and seek medical care from appropriate sources.
Protecting Vulnerable Groups:
• Young children, older adults, and individuals with underlying health conditions such as people with chronic diseases such as diabetes, on cancer treatment, immunicompromised paients or those with low immunity should seek prompt medical attention if experiencing severe symptoms. Healthcare Guidance
For Healthcare Workers:
• Reinforce Infection Prevention and Control (IPC) measures in healthcare facilities.
• Enhance surveillance for acute respiratory infections and report unusual increases to the relevant authorities. Index of suspiciona nd enhanced
• Use appropriate PPE when attending to patients with respiratory symptoms.
• Educate patients on preventive measures and when to seek emergency medical care.
• Provide symptomatic care and promptly refer severe cases to specialist facilities.
Conclusion
The NCDC remains dedicated to protecting the health of Nigerians through continuous surveillance and prompt response to infectious diseases.
We urge the public to adhere to the preventive measures outlined above and to seek medical attention if experiencing symptoms consistent with HMPV infection.
We also emphasize the importance of relying on verified information from the NCDC and WHO.
For emergencies, please contact the NCDC’s toll-free line at 6232 or email us at info@ncdc.gov.ng.
Follow us on our verified social media platforms for timely updates.
Together, we can protect our communities from respiratory infections and ensure a healthier Nigeria.
Contact Information • Toll-Free Number: 6232 • SMS: *** • WhatsApp: *** • Twitter: @NCDCGov • Facebook: @NCDCgov • Instagram: @NCDCgov
Health
Ondo ‘Monkey Tail’ herbal drink kills 49
The Commissioner for Health in the State, Dr Banji Ajaka, who disclosed this on Wednesday night, said the number of affected persons has now climbed to 170.
A locally produced herbal concoctions known as ‘Monkey Tail’ in Ondo State has killed 49 people .
The Commissioner for Health in the State, Dr Banji Ajaka, who disclosed this on Wednesday night, said the number of affected persons has now climbed to 170.
He explained that the latest deaths were recorded in Irele Local Government Area of the state, where eight persons have died from suspected poisoning.
Ajaka disclosed that health authorities had deployed response teams to Irele LGA and other affected communities to conduct surveillance, manage cases and trace the source of the suspected toxic substance.
Health
Bayelsa deploying 19 doctors, 210 nurses to strengthen primary healthcare centres
The commissioner said the deployment of doctors, nurses and midwives would make primary healthcare centres more attractive to residents and encourage women to seek professional care during childbirth.
| Bayelsa State Commissioner for Health, Prof. Seiyefa Brisibe
The Bayelsa State Government has said it will deploy 19 doctors, 210 nurses and midwives, 185 pharmacy technicians and about 50 laboratory medical technicians to primary healthcare centres across the state to strengthen clinical services at the grassroots.
The State Commissioner for Health, Prof. Seiyefa Brisibe, disclosed this on Friday while speaking on the government’s efforts to improve healthcare delivery at the grassroots during a training organised by the Health Emergency Initiative, under the sponsorship of FIRST E&P, tagged First Respondent First Respondent Training and Medical Intervention Programme.
Brisibe said, “We are deploying 19 doctors, 210 nurses and midwives, 185 pharmacy technicians and about 50 laboratory medical technicians to strengthen the clinical component of our primary healthcare centres.”
He said the deployment was aimed at strengthening the clinical component of primary healthcare centres, which, according to him, were often largely run by community health extension workers and environmental health officers.
The commissioner said the deployment of doctors, nurses and midwives would make primary healthcare centres more attractive to residents and encourage women to seek professional care during childbirth.
Health
Gov Mbah Invest in world-class Enugu International Hospital
The hospital, equipped with state-of-the-art medical equipment and advanced digital and electronic systems, is expected to attract top medical professionals from Nigeria and around the world.
Enugu State Governor, Peter Mbah, says the Enugu International Hospital is designed to provide world-class healthcare services to people across all socioeconomic classes.
The Enugu International Hospital is located at Rangers Avenue, Independence Layout, Enugu.
Mbah stated this during a pre-launch tour of the facility ahead of its official commissioning.
The hospital, equipped with state-of-the-art medical equipment and advanced digital and electronic systems, is expected to attract top medical professionals from Nigeria and around the world.
The governor expressed satisfaction with the quality of the equipment installed at the facility, saying the investment would help position Enugu as a medical tourism hub in Nigeria.
He said the hospital would also help reduce the number of Nigerians travelling abroad for specialist medical treatment while creating an environment that would encourage Enugu-trained medical professionals to return home.
According to Mbah, several Enugu-qualified medical practitioners based abroad have already reached out to express interest in working at the international hospital and contributing to the development of the state’s health sector.
The governor further said the facility would create job opportunities for medical graduates, healthcare professionals and other workers, with the potential to boost economic activity in the state.
During the tour, Mbah inspected several specialist units, including the Precision Oncology and Nuclear Medicine Unit, specialised surgery theatres, intensive care units, advanced diagnostics and imaging, and renal care and dialysis facilities.
He also toured the cancer, heart and vascular, nuclear medicine and molecular imaging, neuroscience, and renal centres.
Accompanied by the Director of the facility, Professor Sam Agwu, and other specialists, the governor received briefings on the various services and specialist care the hospital is expected to provide.
The Enugu International Hospital operates as a comprehensive quaternary care facility with more than 300 beds and was established to provide world-class specialist healthcare.
The facility is expected to strengthen access to advanced medical care, support medical professionals, create employment and contribute to Enugu State’s emergence as a destination for medical tourism.
-
Business3 days agoNaira Exchange Rates To Dollar, Pound, Euro…Wednesday, 16 September 2026
-
Entertainment3 days agoEXCLUSIVE: Veteran Nollywood Actor, Olu Jacobs Dies at 84
-
Entertainment3 days agoOlu Jacobs: His Life and Times
-
Health2 days agoOndo ‘Monkey Tail’ herbal drink kills 49
-
Business2 days agoNigerians Speak As Petrol sells N1,500/litre
-
Business1 day agoEmir Sanusi mobilises Kano People “Buy Dangote Refinery’s Shares Now”
-
News2 days agoDigital Economy Minister Says NDPC Now Properly Functional With New HQ
-
News2 days agoUK court jails Nigerian man for masturbating in front of a woman
